XBiotech Inc (XBIT) — Capital Reinvestment Ratio

Latest as of December 2022: 0.05x

XBiotech Inc (XBIT) has a Capital Reinvestment Ratio of 0.05x as of December 2022, meaning it reinvests 0% of its operating cash flow ($2.70 Million) in capital expenditures ($132.00K). See XBiotech Inc (XBIT) net asset quality to measure how much of total assets are equity-financed.

Capital Reinvestment Ratio

0.05x
Capex / Operating Cash Flow

Operating Cash Flow

$2.70 Million
USD

Capital Expenditures

$132.00K
USD

Data as of

Dec 2022
Most recent filing

XBiotech Inc Capital Reinvestment Ratio (2021–2021)

This chart tracks XBiotech Inc's Capital Reinvestment Ratio across 1 annual periods. Check XBiotech Inc investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Annual Capital Reinvestment Ratio for XBiotech Inc (2021–2021)

Year-by-year Capital Reinvestment Ratio for XBiotech Inc from 2021 to 2021. For live market cap and broader valuation context, see XBiotech Inc market cap and net worth.

Year Reinvestment Ratio Operating CF (USD) Capital Expenditures YoY Change
2021 0.05x $69.44 Million $3.52 Million
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow